Hatch-Waxman Safe Harbor Could Get Supreme Court Review

 
• By Brenda Sandburg

High court invites the Solicitor General to submit a brief after GlaxoSmithKline seeks review of a Federal Circuit finding that the safe harbor provision barring infringement claims only pertains to actions to obtain generic approvals; the ruling held GSK’s participation in a study on immunization schedules infringed Classen patents.

More from United States

More from North America